Functional characterization of cysteinyl leukotriene CysLT2 receptor on human coronary artery smooth muscle cells

被引:61
作者
Kamohara, M [1 ]
Takasaki, J [1 ]
Matsumoto, M [1 ]
Matsumoto, S [1 ]
Saito, T [1 ]
Soga, T [1 ]
Matsushime, H [1 ]
Furuichi, K [1 ]
机构
[1] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan
关键词
cysteinyl leukotrienes; LTC4; CysLT(1); CysLT(2); cardiovascular system; coronary smooth muscle; GPCR;
D O I
10.1006/bbrc.2001.5695
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cysteinyl leukotrienes (LTC,, LTD,, and LTE,) are a class of biologically active lipids that exert potent effects on the heart. To assess their roles, we investigated the distribution of their receptors, CysLT(1) and CysLT(2), in the cardiovascular system. CysLT(2) mRNA was detected at high levels in the human atrium and ventricle and at intermediate levels in the coronary artery, whereas CysLT(2) mRNA was barely detected. Further analysis by in situ hybridization revealed that CysLT(2) mRNA was expressed in myocytes, fibroblasts, and vascular smooth muscle cells, but not in endothelial cells. When human coronary smooth muscle cells were stimulated with LTC,, the intracellular calcium concentration increased in a dose-dependent manner, and this action was partially inhibited by nicardipine. Additionally, these cells showed chemotactic responses to LTC4. This is the first report on the physiological role of CysLT(2), and the findings suggest that CysLT(2) has biological significance in the cardiovascular system. (C) 2001 Academic Press.
引用
收藏
页码:1088 / 1092
页数:5
相关论文
共 21 条
  • [1] Differential leukotriene constrictor responses in human atherosclerotic coronary arteries
    Allen, S
    Dashwood, M
    Morrison, K
    Yacoub, M
    [J]. CIRCULATION, 1998, 97 (24) : 2406 - 2413
  • [2] Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma
    Capra, V
    Nicosia, S
    Ragnini, D
    Mezzetti, M
    Keppler, D
    Rovati, GE
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (04) : 750 - 758
  • [3] COLEMAN RA, 1995, ADV PROSTAG THROMB L, V23, P283
  • [4] CORONARY CONSTRICTION BY LEUKOTRIENE-C4, LEUKOTRIENE-D4, AND LEUKOTRIENE-E4 IN THE INTACT PIG-HEART
    EZRA, D
    BOYD, LM
    FEUERSTEIN, G
    GOLDSTEIN, RE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1983, 51 (08) : 1451 - 1454
  • [5] Feuerstein G, 1986, Adv Prostaglandin Thromboxane Leukot Res, V16, P299
  • [6] Gardiner P J, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P49
  • [7] EVIDENCE FOR 2 LEUKOTRIENE RECEPTOR TYPES IN THE GUINEA-PIG ISOLATED ILEUM
    GARDINER, PJ
    ABRAM, TS
    CUTHBERT, NJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 182 (02) : 291 - 299
  • [8] Characterization of the human cysteinyl leukotriene 2 receptor
    Heise, CE
    O'Dowd, BF
    Figueroa, DJ
    Sawyer, N
    Nguyen, T
    Im, DS
    Stocco, R
    Bellefeuille, JN
    Abramovitz, M
    Cheng, R
    Williams, DL
    Zeng, ZZ
    Liu, QY
    Ma, L
    Clements, MK
    Coulombe, N
    Liu, Y
    Austin, CP
    George, SR
    O'Neill, GP
    Metters, KM
    Lynch, KR
    Evans, JF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) : 30531 - 30536
  • [9] Kamohara M, 2000, J BIOL CHEM, V275, P27000
  • [10] LABAT C, 1992, J PHARMACOL EXP THER, V263, P800